By Duke Translational Medicine Institute
In March, 2010, the Robertson Foundation awarded Duke University $10.2 million to develop a state-of-the-art Translational Cell Therapy Center (CT2), a shared resource facility advancing cell-based therapy research—partly in support of the translational work of Drs. Joanne Kurtzberg, Gordon Worley, Ricky Goldstein, and Mohamad Mikati. As a result of this grant, Dr. Kurtzberg created a team of researchers, including Drs. Gordon Worley, Ricky Goldstein, Alan Song, Jessica Sun, Kate Gustafson, and Mohamad Mikati who launched a study to evaluate whether, in children with cerebral palsy (CP), a single intravenous infusion of a child’s own umbilical cord stem cells will cure or at least lessen the severity of the disorder.